Zinc Finger Endonuclease Targeting PSIP1 Inhibits HIV-1 Integration

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2014-05-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.02690-14PMID 24820090PMCID PMC4136077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene editing using a zinc-finger nuclease mimicking the CCR5Δ32 mutation induces resistance to CCR5-using HIV-1.

  2014cited by this paper
• Engineered DNA modifying enzymes: components of a future strategy to cure HIV/AIDS.

  2013cited by this paper
• ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

  2013cited by this paper
• HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

  2013cited by this paper
• Restriction of HIV-1 Replication in Primary Macrophages by IL-12 and IL-18 through the Upregulation of SAMHD1

  2013cited by this paper
• The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.

  2013cited by this paper
• Polymorphic LEDGF/p75 variants support efficient HIV-1 infection ex vivo.

  2013cited by this paper
• LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions

  2013cited by this paper
• Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors

  2013cited by this paper
• Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressors

  2013cited by this paper
• Insights from host genomics into HIV infection and disease: Identification of host targets for drug development.

  2013cited by this paper
• Newer Gene Editing Technologies toward HIV Gene Therapy

  2013cited by this paper
• ExPASy: SIB bioinformatics resource portal

  2012cited by this paper
• HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor

  2012influential reference
• Rare LEDGF/p75 genetic variants in white long-term nonprogressor HIV+ individuals.

  2012cited by this paper
• HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells

  2012cited by this paper
• Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.

  2012cited by this paper
• Characterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression

  2012cited by this paper
• Novel cell and gene therapies for HIV.

  2012cited by this paper
• Hematopoietic-stem-cell-based gene therapy for HIV disease.

  2012cited by this paper
• Zinc finger nucleases: looking toward translation

  2012cited by this paper
• Generation of CD34+ Cells from CCR5-Disrupted Human Embryonic and Induced Pluripotent Stem Cells

  2012cited by this paper
• RNA-guided genetic silencing systems in bacteria and archaea

  2012cited by this paper
• LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs

  2012influential reference
• Genome editing with CompoZr custom zinc finger nucleases (ZFNs).

  2012cited by this paper
• Evidence for the Cure of HIV Infection by CCR5δ32/Δ32 Stem Cell Transplantation

  2011cited by this paper
• A TALE nuclease architecture for efficient genome editing

  2011cited by this paper
• Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

  2011cited by this paper
• HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin

  2011cited by this paper
• Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro Selection

  2011cited by this paper
• On target? Tracing zinc-finger-nuclease specificity

  2011cited by this paper
• Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases

  2011cited by this paper
• Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

  2011cited by this paper
• β5 Integrin Is the Major Contributor to the αv Integrin-Mediated Blockade of HIV-1 Replication

  2011cited by this paper
• An unbiased genome-wide analysis of zinc-finger nuclease specificity

  2011cited by this paper
• Beta5 integrin is the major contributor to the alphaV integrin-mediated blockade of HIV-1 replication

  2011cited by this paper
• Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.

  2010cited by this paper
• Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

  2010cited by this paper
• ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression.

  2010cited by this paper
• Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy

  2010cited by this paper
• LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin.

  2010cited by this paper
• Genome editing with engineered zinc finger nucleases

  2010cited by this paper
• Cell adhesion through alphaV-containing integrins is required for efficient HIV-1 infection in macrophages.

  2009cited by this paper
• Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

  2009cited by this paper
• Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

  2008cited by this paper
• The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication

  2008cited by this paper
• Novel targets for HIV therapy.

  2008cited by this paper
• LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration.

  2007influential reference
• Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting

  2007cited by this paper
• An Essential Role for LEDGF/p75 in HIV Integration

  2006cited by this paper
• Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus

  2006cited by this paper
• Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase*

  2004influential reference
• HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells*

  2003cited by this paper

• Host proteins interacting with integrase of human immunodeficiency virus type 1.

  2025cites this paper
• The role of chromatin in retroviral preintegration complex function

  2025cites this paper
• Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities

  2023cites this paper
• Synthetic modified messenger RNA for therapeutic applications

  2021cites this paper
• Gene-targeted strategies to eliminate HIV latent cells through synthetic activators and suicide lentivectors

  2017cites this paper
• Modulation of chromatin structure by the FACT histone chaperone complex regulates HIV-1 integration

  2017cites this paper
• Antiviral treatment strategies based on gene silencing and genome editing.

  2017cites this paper
• CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells

  2017cites this paper
• SAMHD1 is active in cycling cells permissive to HIV‐1 infection

  2017cites this paper
• CRISPR-mediated Activation of Latent HIV-1 Expression.

  2016cites this paper
• Genome-editing Technologies for Gene and Cell Therapy

  2016cites this paper
• Targeted gene exchange in plant cells mediated by a zinc finger nuclease double cut.

  2016cites this paper
• Potential mechanisms for cell-based gene therapy to treat HIV/AIDS

  2015cites this paper
• Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages

  2015cites this paper
• Impact of Chromatin on HIV Replication

  2015cites this paper
• Application of gene-editing technologies to HIV-1.

  2015cites this paper
• Bone Marrow Gene Therapy for HIV/AIDS

  2015cites this paper